| Drug Type Shared antigen vaccine, Therapeutic vaccine | 
| Synonyms + [1] | 
| Target | 
| Action antagonists | 
| Mechanism HER2 antagonists(Receptor tyrosine-protein kinase erbB-2 antagonists) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Breast Cancer | Preclinical | Austria  | - | |
| Prostatic Cancer | Preclinical | Austria  | - | |
| Breast Cancer | Discovery | United Kingdom  | - | 





